I discovered my father’s secret life after his suicide. It destroyed my mother and left me with scars so deep I struggled for decades
Daily Mail, March 21, 2025
Read the full personal story about Mind Medicine Australia’s Chair, Peter Hunt AM. Read the full PDF article.
Psychedelics with Professor David Nutt
Dr. John Campbell, March 13, 2025
An inspirational interview about psychedelic medicine between Professor David Nutt (UK) and Dr John Campbell (UK).
Dr Ted Cassidy Speaks About Psychedelic-Assisted Psychotherapies in Australia
ABC Drive, February 3, 2025
Psychiatrist Dr Ted Cassidy speaks about treating patients with psychedelic-assisted psychotherapies in Australia.
Listen to the interview from 2:19:39 to 2:28:27.
America rejected MDMA, but Australia didn’t. Here’s why psychedelics have been embraced Down Under
Salon, January 28, 2025
“Our advocacy efforts focussed on a limited rescheduling of MDMA and psilocybin as unregistered medicines, whereas MAPS was pursuing registration of MDMA.”
Optimi Health Completes Second MDMA Shipment to Australia and Expands 2025 Production Forecast to Support Over 5,000 Patients Globally
Optimi Health, January 6, 2025
Optimi Health, a Health Canada-licensed manufacturer of psychedelic pharmaceuticals specialising in natural psilocybin and MDMA, is pleased to announce the completion of its second shipment of GMP-certified MDMA capsules to Australia.
The Australia story: Current status and future challenges for the clinical applications of psychedelics
British Journal of Pharmacology, December 19, 2024
The Australian Therapeutic Goods Administration (TGA) approved the use of psilocybin for treatment-resistant depression and MDMA for PTSD to take effect from 1 July 2023. This paper reviews the background for this decision, its implications for approvals in other jurisdictions, as well as for the development pathways for other psychedelic drugs.
A New Dawn of Psychedelic Therapy
The New Orchard, December 4, 2024
In this podcast episode, our Executive Director Tania de Jong AM, shares her journey as one of Australia’s most influential entrepreneurs and changemakers. This conversation highlights Tania’s pivotal work with the TGA and the successful campaign to legalise psilocybin and MDMA-assisted therapy in Australia, a landmark moment for mental health care. Tune in to learn more about the movement transforming lives through psychedelic-assisted therapies.
JJ’s genes: Son of Lululemon founder ships first load of legal psilocybin to Australia
Forbes, August 21, 2024
Legal suppliers of psilocybin and MDMA are rushing to meet the market following Australia’s recent approval of their clinical use.
Optimi Health Completes Inaugural Export of MDMA Capsules to Australia for PTSD Treatment
Newsfile, August 16, 2024
Optimi Health Corp, a GMP-approved, Health Canada-licensed psychedelics pharmaceutical manufacturer specializing in botanical psilocybin and MDMA, is pleased to announce it has completed the inaugural export of it’s GMP-validated MDMA capsules to Australia for the treatment of PTSD, along with a series of notable corporate developments.
Psychedelics as a serious in investment? These billionaires think so
AFR, August 9, 2024
Australia is among the first countries to use the drugs for treating anxiety, depression and PTSD. A decision in the United States could be pivotal. Australia became the first country to legalise the medical use of psychedelics when the Therapeutic Goods Administration announced changes to the scheduling of psilocybin and MDMA in February last year.
Mental Health Emergency
Australian Life Magazine, August 1, 2024
There is no question that the deteriorating mental health of Australians has been brought to the forefront of the national conversation as one of the sad consequences of the response to COVID-19.
Doubt it not, MDMA is a medicine
Mind Medicine Australia, Drug Science UK and Parea, June 21, 2024
The recent rejection of MDMA-assisted therapy for PTSD by the FDA Psychopharmacologic Drugs Advisory Committee (AdCom) was surprising to many working in the field of mental illness.
Adam’s son died in the Hunter Valley bus crash. In a NSW first, he’ll try MDMA to ease his anguish
The Sydney Morning Herald, June 3, 2024
Associate professor Ranil Gunewardene, who is a psychiatrist and director of Evolution: Medicine Enhanced Therapy, has been approved by the TGA’s authorised prescriber scheme to run the first treatment service and research study in NSW.
Optimi Health gets psychedelics import permit for Mind Medicine Australia shipment
Mugglehead Magazine, May 31, 2024
British Columbia’s psychedelics and natural health products company Optimi Health Corp. (CSE: OPTI) has been making significant progress toward achieving its international distribution goals.
This week, the company obtained a permit to send MDMA and psilocybin capsules to the non-profit charity organization Mind Medicine Australia.
Tania de Jong AM Interview about Psychedelic-Assisted Therapies on 6PR
6PR, May 30, 2024
Tania de Jong AM, Executive Director of Mind Medicine Australia, is interviewed about psychedelic-assisted therapies in Australia.
Psychedelics import deal struck as activists move ahead of regulators
The Australian, May 29, 2024
A deal that paves the way for Australia’s biggest importation of psychedelic medicines has been struck by a charity pushing the therapy, with a Canadian manufacturer pledging to “provide financial assistance to marginalised Australians” to help them access MDMA and psilocybin.
Optimi Health Secures Import Permit from Mind Medicine Australia for MDMA and Psilocybin Capsules
Globe News Wire, May 29, 2024
Company preparing to export 160 doses of MDMA and psilocybin under Australia’s Authorized Prescriber Scheme.
Is it now time to prepare psychiatry for a psychedelic future?
British Journal of Psychiatry, May 20, 2024
“Australia has just rescheduled two drugs controlled under the United Nations Psychotropic Drug Conventions, psilocybin and MDMA, as treatments for treatment-resistant depression and post-traumatic stress disorder respectively. This feature explores the reasons for these developments, the opportunities and challenges they provide to psychiatry communities and how along with health systems these communities might respond to these developments.”
Psychedelic-Assisted therapies Treating Trauma
Australian Jewish News, May 17, 2024
An Australian doctor recently became the first in the world to treat a patient with a controlled dose of MDMA, putting Australia at the forefront of the emerging field of psychedelics.
MDMA Therapy In Australia: Making History One Prescription at a Time
Psychedelics.com, March 25, 2024
On a remarkable day in January 2024, the field of mental health witnessed a history-making moment: the first prescription of MDMA for a patient with chronic, treatment-resistant PTSD outside of a trial setting.